celiprolol has been researched along with Body Weight in 9 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated the influence of celiprolol, a beta 1-blocker with beta 2-agonistic and, possibly, additional weak alpha-receptor antagonistic properties, on insulin sensitivity (SI), glucose homeostasis, and lipid profile in 20 young, healthy, normotensive individuals." | 9.07 | Insulin sensitivity and atrial natriuretic factor during beta-receptor modulation with celiprolol in normal subjects. ( Böhlen, LM; de Courten, M; Hafezi, F; Riesen, W; Shaw, S; Weidmann, P, 1994) |
| "To assess the effects of celiprolol, which is a selective beta1-antagonist with vasodilating properties, on chronic heart failure in the cardiomyopathic hamster UM-X7." | 7.70 | Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure. ( Matsuzaki, M; Nakamura, Y; Ohkusa, T; Ryoke, T; Tanaka, N, 1998) |
| " We investigated the influence of celiprolol, a beta 1-blocker with beta 2-agonistic and, possibly, additional weak alpha-receptor antagonistic properties, on insulin sensitivity (SI), glucose homeostasis, and lipid profile in 20 young, healthy, normotensive individuals." | 5.07 | Insulin sensitivity and atrial natriuretic factor during beta-receptor modulation with celiprolol in normal subjects. ( Böhlen, LM; de Courten, M; Hafezi, F; Riesen, W; Shaw, S; Weidmann, P, 1994) |
| "To assess the effects of celiprolol, which is a selective beta1-antagonist with vasodilating properties, on chronic heart failure in the cardiomyopathic hamster UM-X7." | 3.70 | Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure. ( Matsuzaki, M; Nakamura, Y; Ohkusa, T; Ryoke, T; Tanaka, N, 1998) |
| "5 years) with essential hypertension (WHO stages I-II) who were treated with celiprolol for 4 weeks, and in 12 patients (mean age: 39." | 3.67 | Lipid profile improvement following celiprolol. ( Freischütz, G; Herrmann, JM; von Heyman, F, 1988) |
| "Celiprolol did not activate lipolysis in rat adipocytes in vitro or stimulate human beta(3)-adrenoceptors expressed in Chinese hamster ovary cells as measured with Cytosensor microphysiometer." | 1.31 | Effects of chronic celiprolol treatment on brown fat, feeding, and drinking in fa/fa Zucker rats. ( Huupponen, R; Koulu, M; Luukkaa, V; Malminiemi, K; Pesonen, U; Rouru, J; Savontaus, E, 2000) |
| "Ischemic acute renal failure is associated with vascular endothelial dysfunction." | 1.31 | Effects of vasodilatory antihypertensive agents on endothelial dysfunction in rats with ischemic acute renal failure. ( Goto, A; Hayakawa, H; Hirata, Y; Kakoki, M; Kimura, K; Nagata, D; Nishimatsu, H; Omata, M; Suzuki, E, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsubokou, Y | 1 |
| Kobayashi, N | 1 |
| Mita, S | 1 |
| Yoshida, K | 1 |
| Matsuoka, H | 1 |
| Hayashi, T | 1 |
| Juliet, PA | 1 |
| Miyazaki-Akita, A | 1 |
| Funami, J | 1 |
| Matsui-Hirai, H | 1 |
| Fukatsu, A | 1 |
| Iguchi, A | 1 |
| Böhlen, LM | 1 |
| de Courten, M | 1 |
| Hafezi, F | 1 |
| Shaw, S | 1 |
| Riesen, W | 1 |
| Weidmann, P | 1 |
| Haneda, T | 1 |
| Okamoto, K | 1 |
| Hiroshima, T | 1 |
| Kashiwagi, Y | 1 |
| Miyata, S | 1 |
| Ohi, S | 1 |
| Nakamura, Y | 2 |
| Osaki, J | 1 |
| Hirayama, T | 1 |
| Ogawa, Y | 1 |
| Ryoke, T | 1 |
| Tanaka, N | 1 |
| Ohkusa, T | 1 |
| Matsuzaki, M | 1 |
| Savontaus, E | 1 |
| Rouru, J | 1 |
| Malminiemi, K | 1 |
| Luukkaa, V | 1 |
| Pesonen, U | 1 |
| Koulu, M | 1 |
| Huupponen, R | 1 |
| Kakoki, M | 1 |
| Hirata, Y | 1 |
| Hayakawa, H | 1 |
| Suzuki, E | 1 |
| Nagata, D | 1 |
| Nishimatsu, H | 1 |
| Kimura, K | 1 |
| Goto, A | 1 |
| Omata, M | 1 |
| Totsuka, M | 1 |
| Miyashita, Y | 1 |
| Ito, Y | 1 |
| Oyama, T | 1 |
| Hashiguti, S | 1 |
| Watanabe, H | 1 |
| Shirai, K | 1 |
| Ban, T | 1 |
| Ishihara, H | 1 |
| Yamamoto, K | 1 |
| Kawano, E | 1 |
| Mori, J | 1 |
| Kanechi, M | 1 |
| Herrmann, JM | 1 |
| von Heyman, F | 1 |
| Freischütz, G | 1 |
2 trials available for celiprolol and Body Weight
| Article | Year |
|---|---|
Insulin sensitivity and atrial natriuretic factor during beta-receptor modulation with celiprolol in normal subjects.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Atrial Natriuretic Facto | 1994 |
[The effect of celiprolol hydrochloride for lipid metabolism--especially for the low density lipoprotein particle size].
Topics: Aged; Antihypertensive Agents; Blood Pressure; Body Weight; Celiprolol; Humans; Hypertension; Lipid | 2001 |
7 other studies available for celiprolol and Body Weight
| Article | Year |
|---|---|
Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats.
Topics: Adrenergic beta-Antagonists; Animals; Blotting, Western; Body Weight; Celiprolol; Desoxycorticostero | 2002 |
beta1 antagonist and beta2 agonist, celiprolol, restores the impaired endothelial dependent and independent responses and decreased TNFalpha in rat with type II diabetes.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Animals; Aorta, Abdomin | 2007 |
The role of renal dopamine in the reduction of high blood pressure by beta 1-selective beta-blocker with intrinsic sympathomimetic activity in spontaneously hypertensive rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressu | 1995 |
Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Body Weight; C | 1998 |
Effects of chronic celiprolol treatment on brown fat, feeding, and drinking in fa/fa Zucker rats.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Animals; Blood Glucose; Body Temperature Regulat | 2000 |
Effects of vasodilatory antihypertensive agents on endothelial dysfunction in rats with ischemic acute renal failure.
Topics: Acetylcholine; Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertens | 2000 |
Lipid profile improvement following celiprolol.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Body Weight; Celiprolol; Cholesterol; Cholestero | 1988 |